氧化在严重抑郁症中的抗抑郁作用:一项2b期随机临床试验
Paul S Myles1,2, Jayashri Kulkarni3, Jessica Kasza4
1Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital, Melbourne, Australia.
Biological psychiatry global open science
|June 12, 2025
概括
氧化在重大抑郁症 (MDD) 中显示出有前途的抗抑郁作用. 这项研究发现,与对照组相比,它改善了抑郁症得分和缓解率.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 氧化 (N2O),被称为笑气,作为一个NMDA受体对手.
- 重度抑郁症 (MDD) 是一种普遍且使人虚弱的心理健康状况.
研究的目的:
- 评估氧化在成人中治疗MDD的疗效,安全性和最佳剂量.
- 探索N2O作为一种新型抗抑郁药疗法的潜力.
主要方法:
- 一个2b期随机,双盲试验,涉及81名MDD患者.
- 参与者接受了氧化 (50%或25%的启发) 或控制 (氧气/空气) 在四个1小时的会议.
- 测量结果包括汉密尔顿抑郁评分表 (HAM-D) 的变化,缓解率,CAT-DI和CAT-SS.
主要成果:
- 与对照组相比,氧化显示出较低HAM-D得分的趋势 (p = .051).
- 在第一周内,在氧化组中观察到显著更高的缓解率 (38%对13%,p = .031).
- 在CAT-DI和CAT-SS分数中也注意到了改善,有利于氧化 (p < .05).
结论:
- 氧化在患有多重抑郁症的人群中可能表现出有益的抗抑郁作用.
- 这些发现支持进一步研究N2O作为重大抑郁障碍的潜在治疗方法.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
204
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
204
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
331
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
331


